|
|
Article: Arch Chemicals Reports Third Quarter 2009 Earnings and Narrows Its Full-Year 2009 Earnings Guidance.(Financial report)
- Article from:
- Biotech Week
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ARCH CHEMICALS, INC. (NYSE: ARJ) announced sales for the third quarter of 2009 of $350.5 million, compared to $367.9 million for the third quarter of 2008. Higher pricing and the benefit from the Advantis acquisition were more than offset by lower volumes and unfavorable foreign exchange (see also Arch Chemicals, Inc.).
Third quarter earnings per share for 2009 were $0.41 per share on $10.3 million of income, which included a charge of $0.7 million, net of tax, or $0.03 per share, related to estimated executive severance. Excluding the estimated executive severance, 2009 earnings from continuing operations were $0.44 per share. Third quarter earnings per share ...